sulfaphenazole has been researched along with Hypertension, Pulmonary in 1 studies
Sulfaphenazole: A sulfonilamide anti-infective agent.
sulfaphenazole : A sulfonamide that is sulfanilamide in which the sulfonamide nitrogen is substituted by a 1-phenyl-1H-pyrazol-5-yl group. It is a selective inhibitor of cytochrome P450 (CYP) 2C9 isozyme, and antibacterial agent.
Hypertension, Pulmonary: Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
Excerpt | Relevance | Reference |
---|---|---|
" Thus, we tested if EDHF would regulate vascular tone in rat lungs of control and monocrotaline (MCT)-induced pulmonary hypertension." | 7.74 | Activity of endothelium-derived hyperpolarizing factor is augmented in monocrotaline-induced pulmonary hypertension of rat lungs. ( Fukuchi, Y; Homma, N; Morio, Y; Muramatsu, M; Nagaoka, T; Sato, K; Takahashi, H; Yamamoto, A, 2007) |
" Thus, we tested if EDHF would regulate vascular tone in rat lungs of control and monocrotaline (MCT)-induced pulmonary hypertension." | 3.74 | Activity of endothelium-derived hyperpolarizing factor is augmented in monocrotaline-induced pulmonary hypertension of rat lungs. ( Fukuchi, Y; Homma, N; Morio, Y; Muramatsu, M; Nagaoka, T; Sato, K; Takahashi, H; Yamamoto, A, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Morio, Y | 1 |
Homma, N | 1 |
Takahashi, H | 1 |
Yamamoto, A | 1 |
Nagaoka, T | 1 |
Sato, K | 1 |
Muramatsu, M | 1 |
Fukuchi, Y | 1 |
1 other study available for sulfaphenazole and Hypertension, Pulmonary
Article | Year |
---|---|
Activity of endothelium-derived hyperpolarizing factor is augmented in monocrotaline-induced pulmonary hypertension of rat lungs.
Topics: Animals; Anti-Infective Agents; Apamin; Biological Factors; Charybdotoxin; Cyclic GMP; Endothelium, | 2007 |